BridgeBio Pharma, Inc. (BBIO)
67.39
-0.22
(-0.33%)
USD |
NASDAQ |
Jun 08, 15:37
BridgeBio Pharma EPS Diluted (Quarterly) : -0.8422 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.4688 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Cytokinetics, Inc. | -1.671 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -166.56M |
| Revenue (Quarterly) | 194.52M |
| Total Expenses (Quarterly) | 358.56M |
| Enterprise Value | 15.69B |
| Gross Profit Margin (Quarterly) | 94.64% |
| Profit Margin (Quarterly) | -85.63% |
| Earnings Yield | -5.56% |
| Normalized Earnings Yield | -5.543 |